Double rejection: Nestlé’s cereals cannot carry beta-glucan claim for blood glucose, EFSA repeats

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

The US Federal Trade Commission (FTC) is launching a public inquiry on how the infant formula industry has become so concentrated, as New York City has declared a state... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé Health Science is set to acquire Brazil-based Puravida, expanding its presence across the vitamins, minerals, herbals and supplements segment.

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé’s commitment to end the promotion of formulas for infants from birth to six months of age in all countries by the end of 2022 has been met with... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Clasado Biosciences has received European Food Safety Authority (EFSA) approval extending the novel food status for galactooligosaccharides (GOS) as a novel food in food... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé is dialing up the nutritional content of F&B, fueled by its investments in R&D and recent acquisitions into the health and wellness space. The... Read More

trans